Literature DB >> 212587

Specificity of interferon action in protein synthesis.

P M Yau, T Godefroy-Colburn, C H Birge, T V Ramabhadran, R E Thach.   

Abstract

Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin mimic interferon treatment in that they specifically inhibit the synthesis of certain viral proteins. These specific effects are seen only at very low concentrations of the antibiotics, under conditions where host cellular protein synthesis, as well as cell viability, are not severely reduced. A qualitatively as well as quantitatively close correlation between the effects of the two types of agents has been established for encephalomyocarditis virus, vesicular stomatitis virus and murine leukemia virus protein synthesis. It is concluded that one of the primary mechanisms of interferon action may be a nonspecific retardation of one or more elongation steps, and that this may be sufficient to account for its effects on the replication of certain viruses such as encephalomyocarditis and vesicular stomatitis viruses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212587      PMCID: PMC525853     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells.

Authors:  J Content; B Lebleu; U Nudel; A Zilberstein; H Berissi; M Revel
Journal:  Eur J Biochem       Date:  1975-05

2.  Selective blockage of initiation of host protein synthesis in RNA-virus-infected cells.

Authors:  D L Nuss; H Oppermann; G Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Analysis of VSV mutant with attenuated cytopathogenicity: mutation in viral function, P, for inhibition of protein synthesis.

Authors:  C P Stanners; A M Francoeur; T Lam
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

4.  Synthesis of type C virus particles from murine-cultured cells induced by iododeoxyuridine. V. Effect of interferon and its interaction with dexamethasone.

Authors:  A M Wu; A Schultz; R C Gallo
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

5.  Competition between cellular and viral mRNAs in vitro is regulated by a messenger discriminatory initiation factor.

Authors:  F Golini; S S Thach; C H Birge; B Safer; W C Merrick; R E Thach
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

6.  Relationships between intracisternal type A and extracellular oncornavirus-like particles produced in murine MOPC-460 myeloma cells.

Authors:  D L Robertson; P Yau; D C Dobbertin; T K Sweeney; S S Thach; T Brendler; R E Thach
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

7.  Effect of interferon on exogenous, endogenous, and chroniv murine leukemia virus infection.

Authors:  P M Pitha; W P Rowe; M N Oxman
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

8.  Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract.

Authors:  G C Sen; S L Gupta; G E Brown; B Lebleu; M A Rebello; P Lengyel
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

9.  Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block.

Authors:  D L Nuss; G Koch
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

10.  Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers.

Authors:  R M Friedman; E H Chang; J M Ramseur; M W Myers
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

View more
  8 in total

1.  Comparison of initiation rates of encephalomyocarditis virus and host protein synthesis in infected cells.

Authors:  G Jen; C H Birge; R E Thach
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

2.  Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.

Authors:  A Muñoz; R A García; A Pérez-Aranda
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  Specificity of protein synthesis inhibitors in the inhibition of encephalomyocarditis virus replication.

Authors:  T V Ramabhadran; R E Thach
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

Review 4.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 5.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

6.  Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.

Authors:  Margot Carocci; Priscilla L Yang
Journal:  Antiviral Res       Date:  2016-02-10       Impact factor: 5.970

7.  Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells.

Authors:  T V Ramabhadran; R E Thach
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

8.  The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo.

Authors:  Hui-Jun Dong; Zhao-Hua Wang; Wen Meng; Cui-Cui Li; Yan-Xin Hu; Lei Zhou; Xiao-Jia Wang
Journal:  Viruses       Date:  2018-11-01       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.